Co-Authors
This is a "connection" page, showing publications co-authored by Xueying Zheng and Jianping Weng.
Connection Strength
1.727
-
The zinc finger transcription factor, KLF2, protects against COVID-19 associated endothelial dysfunction. Signal Transduct Target Ther. 2021 07 12; 6(1):266.
Score: 0.239
-
Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies. Pharmacol Rev. 2021 07; 73(3):924-967.
Score: 0.238
-
Glycemic control in children and teenagers with type 1 diabetes around lockdown for COVID-19: A continuous glucose monitoring-based observational study. J Diabetes Investig. 2021 Sep; 12(9):1708-1717.
Score: 0.233
-
Elevated fasting blood glucose within the first week of hospitalization was associated with progression to severe illness of COVID-19 in patients with preexisting diabetes: A multicenter observational study. J Diabetes. 2021 Jan; 13(1):89-93.
Score: 0.228
-
Targeting inflammation and cytokine storm in COVID-19. Pharmacol Res. 2020 09; 159:105051.
Score: 0.222
-
Association between population migration and epidemic control of Coronavirus disease 2019. Sci China Life Sci. 2020 Jun; 63(6):936-939.
Score: 0.219
-
A new model to estimate insulin resistance via clinical parameters in adults with type 1 diabetes. Diabetes Metab Res Rev. 2017 05; 33(4).
Score: 0.176
-
Clinical outcomes of different therapeutic options for COVID-19 in two Chinese case cohorts: A propensity-score analysis. EClinicalMedicine. 2021 Feb; 32:100743.
Score: 0.058
-
Three-month outcomes of recovered COVID-19 patients: prospective observational study. Ther Adv Respir Dis. 2021 Jan-Dec; 15:17534666211009410.
Score: 0.058
-
Decline of SARS-CoV-2-specific IgG, IgM and IgA in convalescent COVID-19 patients within 100 days after hospital discharge. Sci China Life Sci. 2021 03; 64(3):482-485.
Score: 0.056